EFFICACY, SAFETY AND TOLERABILITY OF RECOMBINANT HUMAN HYALURONIDASE-FACILITATED SUBCUTANEOUS INFUSION OF IMMUNOGLOBULIN G IN ADULT PATIENTS WITH PRIMARY IMMUNODEFICIENCIES: PHASE 3 STUDY RESULTS

被引：0

作者：

Stein, Mark ^{[1
]}

Wasserman, Richard L. ^{[2
]}

Melamed, Isaac ^{[3
]}

Rubinstein, Arye ^{[4
,5
]}

Puck, Jennifer ^{[6
]}

Gupta, Sudhir ^{[7
]}

Engl, Werner ^{[8
]}

Leibl, Heinz ^{[8
]}

McCoy, Barbara ^{[8
]}

Yel, Leman ^{[9
]}

Schiff, Richard I. ^{[9
]}

机构：

[1] Allergy Associates Palm Beaches, North Palm Beach, FL USA

[2] DallasAllergyImmunol, Dallas, TX USA

[3] IMMUNOe Hlth Ctr, Centennial, CO USA

[4] Albert Einstein Coll Med, Bronx, NY 10467 USA

[5] Montefiore Hosp, Bronx, NY USA

[6] Univ Calif San Francisco, San Francisco, CA 94143 USA

[7] Univ Calif Irvine, Irvine, CA USA

[8] Baxter BioSci, Vienna, Austria

[9] Baxter BioSci, Westlake Village, CA USA

来源：

JOURNAL OF CLINICAL IMMUNOLOGY | 2014年 / 34卷 / 06期

关键词：

D O I：

暂无

中图分类号：

R392 [医学免疫学]; Q939.91 [免疫学];

学科分类号：

100102 ;

摘要：

引用

页码：727 / 727

页数：1

共 50 条

[21] Population pharmacokinetics of immunoglobulin G after intravenous, subcutaneous, or hyaluronidase-facilitated subcutaneous administration in immunoglobulin-naive patients with primary immunodeficiencies
Li, Zhaoyang
Follman, Kristin
Freshwater, Ed
Engler, Frank
Yel, Leman
INTERNATIONAL IMMUNOPHARMACOLOGY, 2024, 128
[22] Patient Preferences for Recombinant Human Hyaluronidase (RHUPH20)-Facilitated Subcutaneous (SC) Infusion of Immunoglobulin G (IGHY) in Adults with Primary Immunodeficiencies (PI): Phase 3 Study Results
Ito, D.
Ye, X.
Xiong, Y.
Li-McLeod, J.
Schiff, R.
Faivre, P.
JOURNAL OF CLINICAL IMMUNOLOGY, 2014, 34 : S381 - S382
[23] BUDGET IMPACT ANALYSIS OF EXPANDING USE OF RECOMBINANT HUMAN HYALURONIDASE-FACILITATED SUBCUTANEOUS IG INFUSION IN PATIENTS WITH PRIMARY IMMUNODEFICIENCIES (PID) IN BRAZIL
Mendes da Silva, B.
Regis, C.
VALUE IN HEALTH, 2021, 24 : S146 - S146
[24] Safety and Pharmacokinetics (Pk) of Recombinant Human Hyaluronidase (RHUPH20)-Facilitated Subcutaneous (SC) Infusion of Immunoglobulin G (IGSC) (IGHY) in Adult Patients with Primary Immunodeficiencies (PI): Extension Study of a Phase 3 Pivotal Trial
Melamed, Isaac
Wasserman, Richard L.
Stein, Mark R.
Rubinstein, Arye
Puck, Jennifer
Gupta, Sudhir
Engl, Werner
Leibl, Heinz
Yel, Leman
Schiff, Richard I.
JOURNAL OF CLINICAL IMMUNOLOGY, 2014, 34 (03) : 379 - 379
[25] Long-Term Efficacy and Safety of Recombinant Human Hyaluronidase (rHuPH20)-Facilitated Subcutaneous Infusion of Immunoglobulin G (IgG) (HyQvia; IGHy) in Patients with Primary Immunodeficiencies (PI)
Wasserman, Richard L.
Stein, Mark R.
Melamed, Isaac
Kobrynski, Lisa J.
Gupta, Sudhir
Puck, Jennifer M.
Rubinstein, Arye
Engl, Werner
McCoy, Barbara
Leibl, Heinz
Yel, Leman
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 2015, 135 (02) : AB96 - AB96
[26] Efficacy and safety of hyaluronidase-facilitated subcutaneous immunoglobulin 10% in US pediatric patients with primary immunodeficiency disease
Patel, Niraj
Walter, Jolan
Wasserman, Richard
Rubinstein, Arye
Atkinson, T. Prescott
Shepherd, Meagan
Greco, Erin
Russo-Schwarzbaum, Sharon
Duff, Kimberly
Mccoy, Barbara
Chu, Liang-Hui
Li, Zhaoyang
Yel, Leman
CLINICAL IMMUNOLOGY, 2023, 250 : 148 - 149
[27] LONG-TERM SAFETY AND PHARMACOKINETICS OF FACILITATED-SUBCUTANEOUS INFUSION OF HUMAN IMMUNE GLOBULIN G, 10%, AND RECOMBINANT HUMAN HYALURONIDASE: PHASE 3 EXTENSION STUDY IN PATIENTS WITH PRIMARY IMMUNODEFICIENCIES
Melamed, I.
Wasserman, R.
Stein, M. R.
Rubinstein, A.
Puck, J.
Gupta, S.
Engl, W.
Leibl, H.
Gelmont, D. M.
Schiff, R. I.
ANNALS OF ALLERGY ASTHMA & IMMUNOLOGY, 2012, 109 (05) : A98 - A99
[28] Real-World Use of Recombinant Human Hyaluronidase-Facilitated Subcutaneous Infusion of Immunoglobulin G (IG) (IGHy) in Patients with Primary Immunodeficiency Disorders (PIDD)
Rosenbach, Kevin P.
Hughes, Stephanie
Rozen, Leon
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 2016, 137 (02) : AB220 - AB220
[29] REAL WORLD EXPERIENCE OF RECOMBINANT HUMAN HYALURONIDASE-FACILITATED SUBCUTANEOUS INFUSION OF IMMUNOGLOBULIN IN COMMON VARIABLE IMMUNODEFICIENCY
Pinna, K.
Moffitt, K.
ANNALS OF ALLERGY ASTHMA & IMMUNOLOGY, 2016, 117 (05) : S94 - S94
[30] HYALURONIDASE-FACILITATED SUBCUTANEOUS IMMUNOGLOBULIN 10% FOR CIDP: FINAL RESULTS FROM A LONG-TERM SAFETY AND TOLERABILITY STUDY
Hadden, Robert
Andersen, Henning
Bril, Vera
Basta, Ivana
Rejdak, Konrad
Duff, Kim
Greco, Erin
Hasan, Shabbir
Anderson-Smits, Colin
Ay, Hakan
JOURNAL OF THE PERIPHERAL NERVOUS SYSTEM, 2024, 29 : S78 - S79

← 1 2 3 4 5 →